Emergent BioSolutions grants RSUs and options to director
Emergent BioSolutions Inc. reported that director Richard Ronald received equity awards as part of his board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Emergent BioSolutions Inc. reported that director Richard Ronald received equity awards as part of his board compensation. He was granted 25,344 restricted stock units, each representing one share of common stock upon vesting, for Board and Committee service.
He also received 11,296 stock options with an exercise price of $7.99 per share, expiring in 2033. Both the RSUs and options vest on the day prior to the one-year anniversary of the grant date, as long as he remains on the board. After these grants, he directly holds 123,761 common shares.
Insider Trade Summary
Grant/Award: 36,640 shares
Grant/Award
2 txns
Insider
Richard Ronald
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 11,296 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 25,344 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 11,296 contracts (Direct);
Common Stock — 123,761 shares (Direct)
Footnotes (3)
- F1. Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
- F2. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
- F3. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Key Figures
RSU grant size: 25,344 RSUs
Stock options granted: 11,296 options
Option exercise price: $7.99 per share
+3 more
6 metrics
RSU grant size
25,344 RSUs
Annual equity grant for Board and Committee service
Stock options granted
11,296 options
Stock Option (Right to Buy) tied to common stock
Option exercise price
$7.99 per share
Exercise price for newly granted stock options
Shares held after grant
123,761 shares
Director’s direct common stock holdings following RSU grant
Option expiration
2033-04-30
Expiration date for the granted stock options
Director comp allocation
25% to options
Portion of non-employee director compensation used to size option grant
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), Stock Incentive Plan, Annual Grant Vesting Date, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security title of Common Stock"
Stock Incentive Plan financial
"granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Annual Grant Vesting Date financial
"shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date")"
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did director Richard Ronald receive from Emergent BioSolutions (EBS)?
Director Richard Ronald received 25,344 restricted stock units and 11,296 stock options as board compensation. Each RSU converts into one common share upon vesting, and each option allows purchase of one share at a preset exercise price.
How many Emergent BioSolutions (EBS) RSUs were granted in this Form 4 filing?
The filing shows a grant of 25,344 restricted stock units to director Richard Ronald. These RSUs vest the day before the one-year anniversary of the grant date, contingent on his continued board service through that vesting date.
What are the terms of the stock options granted to the EBS director?
The director received 11,296 stock options, each to buy one Emergent BioSolutions common share at an exercise price of $7.99. The options vest on the same one-year schedule as the RSUs and expire in 2033 if not exercised.
When do the new Emergent BioSolutions (EBS) RSUs and options vest?
Both the RSUs and stock options vest on the day prior to the one-year anniversary of the grant date. Vesting requires that Richard Ronald remain a member of Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.
How was the size of the Emergent BioSolutions (EBS) option grant determined?
The number of options, 11,296, was calculated by taking 25% of the total non-employee director compensation value and dividing that amount by the Black-Scholes value of a single option, measured as of the grant date under the company’s Stock Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates